Ligand Pharmaceuticals Inc.

Ligand Pharmaceutical, a global biopharma innovator, develops and licenses therapies for infectious disease, oncology, rare disorders, and more, with blockbuster brands (Kyprolis, Evomela, Veklury) and a robust pipeline of new oncology, rare‑disease, and respiratory treatments.

Headquarters: United States (USA)